Hyperhomocysteinaemia A Risk Factor Worth Considering
|
|
- Benedict Miles
- 5 years ago
- Views:
Transcription
1 REVIEW ARTICLE JIACM 2003; 4(2): Hyperhomocysteinaemia A Risk Factor Worth Considering Pramood C Kalikiri* At least nine well-known risk factors are known to play a role in the development of coronary artery disease (also known as ischaemic heart disease (IHD)) and cerebrovascular accidents (Stroke): heredity, male gender, advancing age, cigarette smoking, high blood pressure, diabetes mellitus, obesity (especially excess abdominal fat), lack of physical activity, and abnormal blood cholesterol levels (more than 200 mg %). The more of these risk factors a person has, the greater the likelihood of IHD and CVA. Clinical research done over the last decade has shown that an elevated plasma level of the amino acid homocysteine is an independent risk factor for atherosclerosis, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and venous thromboembolism 1. Molecular species of homocysteine Homocysteine is a sulphur-containing amino acid formed during methionine metabolism. Its concentration in the plasma or serum is about 10 µmol/ L. However, homocysteine exists in various forms; only trace amounts ( 1%) are in the reduced (sulfhydryl) form, the remaining part is oxidised and exists as various disulphides 2. It can dimerise to homocystine, or form disulphide bonds with proteins to form socalled protein-bound homocysteine. About 80% of homocysteine is bound to albumin (via a disulphide bond) in the plasma, whereas the remaining 20% exists as free disulphides. Outline of methionine/homocysteine metabolism Homocysteine is not a dietary constituent and is not incorporated into proteins but is exclusively formed as an intermediary product of methionine metabolism. Through the action of methionine adenosyltransferase, methionine is converted to S-adenosylmethionine (SAM), which is the major biological methyl donor required for numerous cellular processes, including the formation of proteins, nucleic acids, and creatinine. These reactions are catalysed by various methyltransferases that demethylate S- adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH). S-adenosyl homocysteine (SAH) is hydrolysed to simultaneously produce homocysteine and adenosine by SAH hydrolase. The SAH hydrolase catalysed step is bidirectional and favours condensation of homocysteine and adenosine 3. Once homocysteine is formed, it may be salvaged to methionine by remethylation, or degraded to cysteine by trans-sulfuration. Remethylation to methionine is in most tissues catalysed by the ubiquitous enzyme, methionine synthase (MS). This enzyme uses vitamin B12 as co-factor, and methyltetrahydrofolate as methyl donor. 5- methyltetrahydrofolate is formed from folic acid by the vitamin B2-dependent enzyme methyl tetrahydrofolate reductase (MTHFR). Reconversion of homocysteine to methionine also contributes to the maintenance of intracellular stores of tetrahydrofolate. Homocysteine may also be converted to methionine by betainehomocysteine methyltransferase using betaine as a methyl donor. This reaction is probably confined to the liver and possibly the kidney. Two vitamin B 6 -dependent enzymes are involved in the trans-sulfuration pathway. The enzyme cystathionine beta synthase (CBS) first condenses homocysteine with serine to form cystathionine, which is then cleaved into cysteine and a-ketobutyrate by cystathionine lyase. Cysteine may be utilised in the synthesis of proteins or as a precursor of the antioxidant glutathione. The trans-sulfuration of homocysteine to cysteine is irreversible, and therefore directs homocysteine to catabolism via cysteine to sulphates as the final product. * PhD - I st Year, Department of Physiology, Louisiana State University Medical Center, New Orleans, LA-70112, USA.
2 Under normal metabolic circumstances, there is a strict balance between homocysteine formation and elimination. Usually about 50% of the homocysteine formed is remethylated to methionine. When protein or methionine intake is in excess, a larger proportion is catabolised by the trans-sulfuration pathway. If there is an increased formation of homocysteine relative to its consumption, homocysteine is excreted from the cells. This can be detected as an increased level of homocysteine in plasma/serum or in the urine. Thus, homocysteine, an intermediate in protein metabolism, is involved in conversion of the amino acid methionine to cysteine or in remethylation to form methionine. Metabolism of homocysteine is by pathways which re-methylate it (and which require vitamin B 12, B 2, and folic acid), or by a trans-sulfuration pathway which requires vitamin B 6. Methionine in the diet is the main source of homocysteine in the blood. Animal proteins provide about three times as much methionine as plant protein. Homocysteine in blood (and elsewhere) is a product of how much methionine is eaten, mainly in protein, and how much is metabolised, which in turn may be affected by amounts of B vitamins and folate available. Aetiology of elevated homocysteine levels Elevated homocysteine levels are often the result of decreased activity of key enzymes involved in conversion of the amino acid methionine to cysteine or in remethylation to form methionine. A plasma homocysteine concentration exceeding 15 µmol per L is now termed hyperhomocysteinaemia 4. Normal levels of fasting plasma homocysteine are considered to be between 5 and 15 µmol/l. Moderate, intermediate, and severe hyperhomocysteinaemia refer to concentrations between 16 and 30, between 31 and 100, and >100 µmol/ L, respectively 5. The most common inherited form of hyperhomocysteinaemia results from an alteration in the gene encoding the enzyme methylene tetrahydrofolate reductase. Less often, the cause of hyperhomocysteinaemia is heterozygous cystathionine b-synthase deficiency. Homozygous form of cystathionine b-synthase deficiency results in homocystinuria, which is a rare but severe condition in which total homocysteine concentrations generally exceed 100 µmol per L, 148 Journal, Indian Academy of Clinical Medicine Vol. 4, No. 2 April-June 2003
3 sometimes even reaching levels upto 500 µmol per L if the disorder is untreated. Individuals with this inherited disorder are known to have severe hyperhomocysteinaemia and a variety of abnormalities, including a high incidence of vascular pathology that may result in early death from myocardial infarction, stroke, or pulmonary thromboembolism. Hyperhomocysteinaemia can be acquired as the result of dietary deficiencies of folate, vitamin B 12 and/or vitamin B 6. These vitamins are necessary co-factors for the optimal function of methylene tetrahydrofolate reductase, methionine synthase, and cystathionine b-synthase. Deficiencies in the absorption or transport of these vitamins can also cause hyperhomocysteinaemia. Pathogenesis of atherosclerosis in hyperhomocysteinaemia The exact mechanisms by which hyperhomocysteinaemia causes atherosclerosis are not completely understood. Animal models of hyperhomocysteinaemia show altered vascular function, including the promotion of smooth muscle cell growth and the development of atherosclerosis. Abnormal homocysteine levels appear to contribute to coronary artery disease by the following mechanisms: (a) causing endothelial dysfunction. A dysfunctional endothelium is an early marker of atherosclerosis and thrombosis 6 ; (b) causing marked impairment of endothelium-dependent vasodilatation in response to acetylcholine and adenosine diphosphate (ADP) 7 ; (c) inducing oxidative stress on endothelial cells which is mediated by hydrogen peroxide 8 ; (d) promoting the growth and proliferation of vascular smooth muscle 9 ; (e) decreasing the bioavailability of Nitric Oxide by forming S-nitrosohomocysteine 10 ; (f ) a direct toxic effect that damages the cells lining the inside of the arteries; (g) interference with clotting factors ; (h) oxidation of low-density lipoproteins (LDL) 4,19-21 ; (i) because the SAH hydrolase catalysed step is bidirectional, elevated homocysteine may cause cardiovascular disease by a reduction in plasma or tissue adenosine levels 22. Adenosine has a wide variety of protective effects on cardiovascular homoeostasis. It causes coronary and cerebral artery vasodilatation, increases blood flow in the microcirculation, inhibits platelet aggregation and decreases proliferation or growth of smooth muscle or mesangial cells 23. Relationship between blood homocysteine levels and severity of coronary artery disease The researchers have found a linear relationship between blood homocysteine levels and severity of the coronary blockages: For every 10% elevation of homocysteine, there was nearly the same (10%) rise in the risk of developing coronary artery disease 24. A similar percentage increase in cholesterol levels would imply about a 20% increased risk for heart disease. This study is important, because it is the first of its size to show a positive correlation with risk of atherosclerosis and also suggests that elevated blood homocysteine levels are as important as high blood cholesterol levels and can operate independently. Studies also suggest a linear relationship between the number of blocked arteries and homocysteine levels (both fasting and postload), regardless of sex, age, or any other risk variables, i.e., more severe the blockages in the coronary arteries, the higher the homocysteine levels. Blood homocysteine assays Most clinical laboratories use assays that report total homocysteine concentrations. Total homocysteine, abbreviated as thcy, is a methodological term and refers to the concentration of homocysteine obtained after plasma/serum has been treated with a reductant which converts the free and bound disulfides into their respective sulfhydryl compounds. Blood should be collected in tubes containing an anticoagulant such as ethylenediamine tetraacetic acid (EDTA), heparin, or sodium citrate. The specimen should be spun (centrifuged) within 30 minutes of collection to avoid a false elevation caused by the release of homocysteine from red blood cells (RBC s), a process that continues at room temperature 25. Once the plasma is separated from cells, it can be stored refrigerated for several weeks or frozen for several months. The total homocysteine concentration can also be measured in serum samples. However, the reference intervals are slightly higher than those for plasma, in part because of the continued release of homocysteine from red blood cells and the delay required for sample clotting before centrifugation. Journal, Indian Academy of Clinical Medicine Vol. 4, No. 2 April-June
4 Because variable changes in homocyst(e)ine levels have been observed postprandially 25, it is customary to obtain measurements in the fasting state. The majority of the assays are based on chromatographic techniques; high performance liquid chromatography (HPLC) with fluorescence detection is the method most commonly used 26. Normal levels of fasting plasma homocysteine are considered to be between 5 and 15 µmol/l. Screening for plasma homocysteine levels is not widely available and may cost $ 200, which is not currently covered by insurance. However, it may be useful in patients with a personal or family history of cardiovascular disease, but in whom the well-established risk factors (smoking, high blood cholesterol, high blood pressure, diabetes, physical inactivity and obesity) don t exist (American Heart Association). Management of patients with hyperhomocysteinaemia Detoxification of excess homocysteine requires methylating factors such as folic acid, vitamin B 12, and trimethylglycine (TMG). Methylation factors donate methyl groups to homocysteine and function to convert (remethylate) homocysteine back into the non-toxic amino acid methionine. Some individuals may also require higher amounts of vitamin B 6, which converts homocysteine to cysteine and sulfate via trans-sulfuration pathway. Regardless of the cause of hyperhomocysteinaemia, most patients should derive some benefit from vitamin supplementation via the conversion of homocysteine back to methionine (remethylation) or to cysteine (trans-sulfuration). Homocysteine levels usually decrease after a few weeks of therapy and normalise within six to eight weeks. In a placebo-controlled study 27, a combination of multiple agents including folic acid (0.65 mg/d), vitamin B 6 (10 mg/d), and vitamin B 12 (0.4 mg/d) was very effective in reducing homocysteine levels in patients with moderate or intermediate hyperhomocysteinaemia. At the time of the initial evaluation, a serum B 12 level should be obtained to ensure that intake of this vitamin is adequate before folic acid supplementation is initiated because the neurological features associated with vitamin B 12 deficiency persist with folic acid supplementation despite improvement in other symptoms and signs of B 12 deficiency. A recent report of the Food and Nutrition Board of the Institute of Medicine has recommended an upper limit of 1 mg/d folic acid on the basis of the possibility that higher doses may mask signs of vitamin B 12 deficiency in some subjects. Vitamin B 12 deficiency can still be detected clinically by the history and physical examination, along with serum methylmalonic acid or vitamin B 12 measurement, factors that are not altered by folic acid supplementation 28. Conclusion Although there is considerable epidemiological evidence for a relationship between plasma homocysteine and coronary artery disease, not all prospective studies have supported such a relationship. Reductions in homocysteine levels may be achieved by proper diet and vitamin supplementation. It has not yet been proved, however, that a reduction in homocysteine levels reduces the risk of coronary artery disease. The results of clinical trials to determine the potential benefit of reducing homocysteine concentrations are not yet available. However, given the substantial risk associated with hyperhomocysteinaemia and the fact that homocysteine levels can be lowered with non-toxic vitamin therapy; the screening of patients at high risk for cardiovascular disease appears to be warranted. Until studies have been completed, it is prudent to advise patients with, or at high risk, for vascular disease, to take enough folic acid and vitamins B 6 and B 12 in their diet. They should eat at least five servings of fruits and green, leafy vegetables daily (American Heart Association). References 1. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinaemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41: Ueland PM. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev 1982; 34: Robinson K, Mayer E, Jacobsen DW. Homocysteine and coronary artery disease. Cleve Clin J Med 1994; 61: Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)- inaemia as a risk factor for occlusive vascular disease. Ann Rev Nutr 1992; 12: Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: Journal, Indian Academy of Clinical Medicine Vol. 4, No. 2 April-June 2003
5 7. Lentz SR, Sobey CG, Piegors DJ et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inaemia. J Clin Invest 1996; 98: Hultberg B, Andersson A, Isaksson A. The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology 1997; 123: Tsai JC, Wang H, Perella MA et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: Stamler JS, Osborne JA, Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 1993; 91: Hajjar KA, Mauri L, Jacovina AT et al. Tissue plasminogen activator binding to the annexin II tail domain - direct modulation by homocysteine. J Biol Chem 1998; 273: Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein-c activation by arterial and venous endothelial cells. Blood 1990; 75: Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein-c activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88: Hayashi T, Honda G, Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 1992; 79: Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 1993; 92: Fryer RH, Wilson BD, Gubler DB et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993; 13: Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta 1987; 917: Durand P, Lussier-Cacan S, Blache D. Acute methionine loadinduced hyperhomocysteinaemia enhances platelet aggregation thromboxane biosynthesis, and macrophage derived tissue factor activity in rats. FASEB J 1997; 11: Domagala TB, Libura M, Szczeklik A. Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation. Thromb Res 1997; 87: Ya-Fei Chen, Pin-Lan Li, Ai-Ping Zou. Effect of hyperhomocysteinaemia on plasma or tissue adenosine levels and renal function. Circulation 2002; 106: Biaggioni I, R Mosqueda-Garcia. Adenosine in cardiovascular homeostasis and the pharmacologic control of its activity. In: Laragh JH, Brenner BM, eds. Hypertension, Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven; 1995; Verhoef P, Others. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1997; 17: Ueland PM, Refsum H, Stabler SP et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991; 29: Ubbink JB, Becker PJ, Vermaak WJ, Delport R. Results of B- vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995; 41: Dickinson CJ. Does folic acid harm people with vitamin B 12 deficiency? QJM 1995; 88: Journal, Indian Academy of Clinical Medicine Vol. 4, No. 2 April-June
Nitrous Oxide induced Elevation of Plasma Homocysteine and Methylmalonic Acid Levels and their Clinical Implications
SHORT COMMUNICATION JIACM 2005; 6(1): 48-52 Abstract Nitrous Oxide induced Elevation of Plasma Homocysteine and Methylmalonic Acid Levels and their Clinical Implications Pramood C Kalikiri*, Reena G Sachan*
More informationNitrous Oxide Induced Elevation Of Plasma Homocysteine And Methylmalonic Acid Levels And Their Clinical Implications
ISPUB.COM The Internet Journal of Anesthesiology Volume 8 Number 2 Nitrous Oxide Induced Elevation Of Plasma Homocysteine And Methylmalonic Acid Levels And Their Clinical Implications P Kalikiri, R Sachan
More informationHomocysteine (plasma, urine, dried blood spots)
Homocysteine (plasma, urine, dried blood spots) 1 Name and description of analyte 1.1 Name of analyte Homocysteine 1.2 Alternative names None 1.3 NLMC code To follow 1.4. Function(s) of analyte Homocysteine
More informationHOMOCYSTEINE METABOLISM
Annu. Rev. Nutr. 1999. 19:217 46 Copyright c 1999 by Annual Reviews. All rights reserved HOMOCYSTEINE METABOLISM J. Selhub Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston,
More informationHomocystinuria due to CBS deficiency
Homocystinuria due to CBS deficiency Introductory information Written by: U. Wendel, P. Burgard & V. Konstantopoulou Reviewed & Revised for North America by: S. van Calcar HCU Homocystinuria Homocystine
More informationClinical Policy: Homocysteine Testing Reference Number: CP.MP.121
Clinical Policy: Reference Number: CP.MP.121 Effective Date: 08/16 Last Review Date: 08/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationHomocysteine Determination in Plasma
omocysteine Determination in Plasma Bruce Peary Solomon, Ph.D. Chester T. Duda, Ph.D. Bioanalytical Systems, Inc. West Lafayette, IN E-mail: bp@bioanalytical.com Recent publications suggest that high homocysteine
More informationMetabolism of. Sulfur Containing Amino Acids
Metabolism of Sulfur Containing Amino Acids Methionine S CH 3 CH 2 cysteine CH 2 SH CH 2 CHNH 2 COOH CHNH 2 COOH Essential amino acid Non-polar amio acid Glucogenic amino acid Methionine IMPORTANCE: As
More informationIndependent Risk Factors of Cardiovascular Disease Achieving Healthy Homocysteine Levels
Independent Risk Factors of Cardiovascular Disease Achieving Healthy Homocysteine Levels AUTHORS: JON LEGERE, BRADLEY RALPH, DR. RON LEGERE 15344 N 83RD WAY, SCOTTSDALE, AZ 85260 TEL: 800.528.3144 EMAIL:
More informationThe effect of nickel on homocysteine metabolism in patients with end-stage renal disease on hemodialysis and in vitro in peripheral mononuclear cells
SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) The effect of nickel on homocysteine metabolism in patients with end-stage renal disease on hemodialysis and in vitro in peripheral mononuclear
More informationCBS Deficient Homocystinuria.
CBS Deficient Homocystinuria. Kenneth N. Maclean PhD University of Colorado School of Medicine Department of Pediatrics The methionine cycle Alternative metabolic fates for Hcy Extrusion into the extracellular
More informationhttp://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current
More informationHyperhomocysteinemia is known to be an. Methylenetetrahydrofolate Reductase Gene Polymorphism. Relation to Blood Pressure and Cerebrovascular Disease
AJH 1998;11:1019 1023 BRIEF COMMUNICATIONS Methylenetetrahydrofolate Reductase Gene Polymorphism Relation to Blood Pressure and Cerebrovascular Disease Yukiko Nakata, Tomohiro Katsuya, Seiju Takami, Noriyuki
More informationBiochemistry: A Short Course
Tymoczko Berg Stryer Biochemistry: A Short Course Second Edition CHAPTER 31 Amino Acid Synthesis 2013 W. H. Freeman and Company Chapter 31 Outline Although the atmosphere is approximately 80% nitrogen,
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationHomocysteine enzymatic assay A strong, independent risk factor for cardiovascular disease
References 1 World Health rganization. Fact sheet No. 317. Cardiovascular diseases (CVDs). Available at: www.who.int/mediacentre/factsheets/fs317/en/index.html [Accessed ctober 19, 2012]. 2 World Health
More informationHYPERHOMOCYSTEINEMIA: RELATION TO CARDIOVASCULAR DISEASE (PDF) HOMOCYSTEINE AND RELATED B-VITAMIN STATUS IN COELIAC
PDF HYPERHOMOCYSTEINEMIA: RELATION TO CARDIOVASCULAR DISEASE (PDF) HOMOCYSTEINE AND RELATED B-VITAMIN STATUS IN COELIAC 1 / 5 2 / 5 3 / 5 homocysteine related vitamins pdf Hyperhomocysteinemia: Relation
More informationAssociation between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease
Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease ROXANA BUZAŞ, CORINA ŞERBAN, IOANA SUCEAVA, DANIEL LIGHEZAN University
More informationHOMOCYSTEINE. A Strong Risk Factor for Cardiovascular Disease INNOVATIONS IN CLINICAL DIAGNOSTICS
HOMOCYSTEINE A Strong Risk Factor for Cardiovascular Disease INNOVATIONS IN CLINICAL DIAGNOSTICS About Diazyme Diazyme Laboratories, Inc., an affiliate of General Atomics, is located in Poway, California.
More informationAMINO ACID METABOLISM
AMINO ACID METABOLISM Synthesis of Urea in Liver The series of reactions that form urea is known as the Urea Cycle or the Krebs-Henseleit Cycle. The urea cycle operates only to eliminate excess nitrogen.
More informationHOMOCYSTEINE (H(e)) is a nonprotein-forming, thiolcontaining
0163-769X/99/$03.00/0 Endocrine Reviews 20(5): 738 759 Copyright 1999 by The Endocrine Society Printed in U.S.A. Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis
More informationHigh Blood Pressure in Irish Adults
High Blood Pressure in Irish Adults Preliminary findings and lessons learned from two JINGO cohorts Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Mortality due
More informationCardioGenomicPlus Profile
CardioGenomicPlus Profile Patient: SAMPLE PATIENT DOB: Sex: MRN: Apo E Chromosome 19 APOE APO E2: cys / cys APO E3: cys / arg APO E4: arg / arg The two SNPs lead to 3 possible variants for each chromosome,
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationSerum Total Homocysteine and Coronary Heart Disease
International Journal of Epidemiology O International Eptctemlotoglcal Association 1995 Vol. 24, No. 4 Printed In Great Britain Serum Total Homocysteine and Coronary Heart Disease EGIL ARNESEN,* HELGA
More informationFat Metabolism, Insulin and MTHFR
Fat Metabolism, Insulin and MTHFR BCAA, SAMe and ACAT Carolyn Ledowsky Overview of This Presentation 1. Fat Metabolism and MTHFR 2. SAMe and Fat Metabolism 3. Acetyl Co A and Fat Metabolism 4. How to Maintain
More informationHomocysteine (Hcy) A Strong Risk Factor for Cardiovascular Disease. A guide to Homocysteine, correlation to human disease, and various testing methods
Homocysteine (Hcy) A Strong Risk Factor for Cardiovascular Disease A guide to Homocysteine, correlation to human disease, and various testing methods Table of Contents 1. Introduction...3 2. What is homocysteine?...4
More informationHomocystinuria: what about mild
Postgrad Med J 1996; 72: 513-518 ( The Fellowship of Postgraduate Medicine, 1996 Classic diseases revisited Summary Hyperhomocysteinaemia is associated with an increased risk of atherosclerotic vascular
More informationEVERYDAY CLINICAL APPLICATION OF TELOMERE AND AGING SUPPORT PRESENTED BY: Fred Pescatore, MD, MPH, CCN
EVERYDAY CLINICAL APPLICATION OF TELOMERE AND AGING SUPPORT PRESENTED BY: Fred Pescatore, MD, MPH, CCN Financial Disclosure: Consultant to DaVinci Labs AGENDA Overview of the following: Methylation Telomere
More informationImpaired Homocysteine Metabolism and Atherothrombotic Disease. Philippe Durand, Michel Prost, Nadine Loreau, Suzanne Lussier-Cacan, and Denis Blache
0023-6837/01/8105-645$03.00/0 LABORATORY INVESTIGATION Vol. 81, No. 5, p. 645, 2001 Copyright 2001 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. MINIREVIEW Impaired Homocysteine
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationWhy Use Genetic Testing in Practice?
Pure Encapsulations is committed to producing the most complete line of research-based nutritional supplements. Available through health professionals, finished products are pure and hypoallergenic to
More information9 Metabolic trigger: control of methionine metabolism
9 Metabolic trigger: control of methionine metabolism M.V. Martinov 1,V.M.Vitvitsky 1,E.V.Mosharov 2,R.Banerjee 2,F.I.Ataullakhanov 1 1 National Research Center for Hematology, Moscow, Russia 125167 2
More informationElevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction
Bangladesh Med Res Counc Bull 2012; 38: 9-13 Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction Abstract Alam N, Khan
More informationHyperhomocysteinemia is an independent risk factor for. Improved Vascular Endothelial Function After Oral B Vitamins
Improved Vascular Endothelial Function After Oral B Vitamins An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine John C. Chambers, MD; Per M. Ueland, MD; Omar A. Obeid, PhD; Jane
More informationFolate/folic acid and interactions with other B vitamins This talk will cover
Scientific update on B vitamins: Folate/folic acid and interactions with other B vitamins Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Folate/folic acid and interactions
More informationVDR GENE (Vitamin D Receptor)
12 GENES EXPLAINED. VDR GENE (Vitamin D Receptor) What is the purpose of the VDR gene? The Vitamin D receptor gene influences the ability to efficiently use vitamin D. Healthy bone density and strength
More informationHomocysteine and its Catabolism UNDERSTANDING THE METHYLATION PATHWAY
Homocysteine and its Catabolism UNDERSTANDING THE METHYLATION PATHWAY Objectives Undearstand the basics of methylation Learn the three disposal routes of homocysteine catabolism Understand the clinical
More informationFolic Acid Improves Arterial Endothelial Function in Adults With Hyperhomocystinemia
Journal of the American College of Cardiology Vol. 34, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00469-6 Folic
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationREVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Causal or Casual? REVIEW ARTICLE William G. Christen, ScD; Umed A. Ajani, MBBS; Robert J. Glynn, ScD; Charles H. Hennekens, MD
More informationAnticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT
Haemostasis Thrombosis Phases Endogenous anticoagulants Stopping blood loss Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT Vascular Platelet
More informationGeneral introduction
1 General introduction Essentials of homocysteine and 1-carbon metabolism Cardiovascular disease (CVD) is one of the most prominent causes of death in the modern world. Research has shown that a combination
More informationPrevalence of Hyperhomocysteinemia in Patients with Predialysis Chronic Kidney Disease after Folic Acid Food Fortification of the Canadian Food Supply
Prevalence of Hyperhomocysteinemia in Patients with Predialysis Chronic Kidney Disease after Folic Acid Food Fortification of the Canadian Food Supply by Linda Jane Paterson A thesis submitted in conformity
More informationReview Article. Mechanisms of Disease
Review Article Mechanisms of Disease F RANKLIN H. EPSTEIN, M.D., Editor HMCYSTEINE AND ATHERTHRMBSIS GERGE N. WELCH, M.D., AND JSEPH LSCALZ, M.D., PH.D. IN 1969, McCully made the clinical observation linking
More informationPredictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study
Clinical Chemistry 49:1 113 120 (2003) Lipids, Lipoproteins, and Cardiovascular Risk Factors Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Lina
More informationKEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers
CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes
More information!!"#$%&'#()*+,-).(&"/+0&'12'
LAB #: Sample Report PATIENT: Sample Patient ID: SEX: Female DOB: 01/01/1985 AGE: 33 CLIENT #: 12345 DOCTOR: Sample Doctor Doctors Data Inc 3755 Illinois Ave St. Charles, IL 60174 U.S.A.!!"#$%&'#()*+,-).(&"/+0&'12'
More informationCardiovascular risk factor you have never heard of. What you don t know might kill you
Cardiovascular risk factor you have never heard of What you don t know might kill you Causes of mortality, United States Lifestyle related health conditions are among the main causes of mortality Center
More informationLipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation
Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-
More informationnumber Done by Corrected by Doctor Dr.Diala
number 32 Done by Mousa Salah Corrected by Bahaa Najjar Doctor Dr.Diala 1 P a g e In the last lecture we talked about the common processes between all amino acids which are: transamination, deamination,
More informationHomocysteine and thiol metabolites in vitamin B 12 deficiency
Clinical Science (2001) 100, 111 116 (Printed in Great Britain) 111 Homocysteine and thiol metabolites in vitamin B 12 deficiency L. R. RANGANATH*, M. BAINES and N. B. ROBERTS *Department of Chemical Pathology,
More informationResearch Article. Effect of folic acid on serum homocysteine levels in patients with cardiovascular diseases (CVD)
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(3):1141-1148 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Effect of folic acid on serum homocysteine levels
More informationTargeting intracellular arginine / asymmetric dimethylarginine (ADMA).
Targeting intracellular arginine / asymmetric dimethylarginine (ADMA). From bench to practice: Novel anti-atherogenic strategies to improve endothelial function Rainer H. Böger, M.D. Institute of Clinical
More informationEFFECT OF NITROUS OXIDE EXPOSURE DURING SURGERY ON THE HOMOCYSTEINE CONCENTRATIONS OF CHILDREN. Dubraiicka Pichardo
EFFECT OF NITROUS OXIDE EXPOSURE DURING SURGERY ON THE HOMOCYSTEINE CONCENTRATIONS OF CHILDREN by Dubraiicka Pichardo A thesis submitted in conformity with the requirements for the degree of M.Sc. Graduate
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationEffect of Folic Acid on Serum Homocysteine Levels in Patients with Cardiovascular Diseases (CVD)
Human Journals Research Article August 2015 Vol.:4, Issue:1 All rights are reserved by Narmatha.M.P et al. Effect of Folic Acid on Serum Homocysteine Levels in Patients with Cardiovascular Diseases (CVD)
More informationHomocysteine is an amino acid produced as an intermediate
CLINICAL REVIEW Homocysteine and Vascular Disease Christopher A. Friedrich, MD, PhD, and Daniel J. Rader, MD Homocysteine is an amino acid produced as an intermediate product in the metabolism of methionine,
More informationHomocysteine, Vitamins, and Prevention of Vascular Disease
MILITARY MEDICINE, 169, 4:325, 2004 Homocysteine, Vitamins, and Prevention of Vascular Disease Guarantor: Kilmer S. McCully, MD Contributor: Kilmer S. McCully, MD Within the past four decades, the efforts
More informationRelationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction
Relationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction Durdi Qujeq *1, Laia Hossini 1 and M. Taghi Salehi Omran 2
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationThe Role of Homocysteine in Human Health
K.J. McLaughlin, B.P.E., B.Sc., D.C., MA.Sc., R.N.C. 1 Introduction For the last two decades, the Modus Operandi of most health care providers managing their patients with atherosclerosis was to prescribe
More informationTHE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY
ALCOHOL NEGATIVE CORRELATION BETWEEN 1-2 DRINKS PER DAY AND THE INCIDENCE OF CARDIOVASCULAR DISEASE SOME HAVE SHOWN THAT EVEN 3-4 DRINKS PER DAY CAN BE BENEFICIAL - WHILE OTHERS HAVE FOUND IT TO BE HARMFUL
More informationHOMOCYSTEINE AND CARDIOVASCULAR DISEASE
Annu. Rev. Medicine 1998. 49:31 62 Copyright 1998 by Annual Reviews Inc. All rights reserved HOMOCYSTEINE AND CARDIOVASCULAR DISEASE H. Refsum, MD and P. M. Ueland, MD Department of Pharmacology, University
More informationDemonstration of Rapid Onset Vascular Endothelial Dysfunction After Hyperhomocysteinemia. An Effect Reversible With Vitamin C Therapy
Demonstration of Rapid Onset Vascular Endothelial Dysfunction After Hyperhomocysteinemia An Effect Reversible With Vitamin C Therapy John C. Chambers, MRCP; Andrew McGregor, RGN; Jeff Jean-Marie; Omar
More informationMaintain Cholesterol
Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured
More informationPrevalence Of Hyperhomocysteinemia In Patients With Predialysis Chronic Kidney Disease After Folic Acid Food Fortification Of The Canadian Food Supply
Prevalence Of Hyperhomocysteinemia In Patients With Predialysis Chronic Kidney Disease After Folic Acid Food Fortification Of The Canadian Food Supply Pauline B. Darling PhD RD Research Team Research Team
More informationOrganic Acids Part 10 Dr. Jeff Moss
Using organic acids to resolve chief complaints and improve quality of life in chronically ill patients Part X Jeffrey Moss, DDS, CNS, DACBN jeffmoss@mossnutrition.com 413-530-08580858 (cell) 1 2 Sulfur
More informationMidterm 2. Low: 14 Mean: 61.3 High: 98. Standard Deviation: 17.7
Midterm 2 Low: 14 Mean: 61.3 High: 98 Standard Deviation: 17.7 Lecture 17 Amino Acid Metabolism Review of Urea Cycle N and S assimilation Last cofactors: THF and SAM Synthesis of few amino acids Dietary
More informationTechnical Overview of Micronutrient Testing
Technical Overview of Micronutrient Testing J.F. Crawford, Ph. D. SpectraCell Laboratories, Inc. Houston, TX Recent Publications Antioxidant supplementation increases morbidity and mortality. JAMA, 2007
More informationin a population with low plasma
518 Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey S L Tokgözoğlu E Atalar K Aytemir N Özer K Övünç S Kes Paediatric Genetics, Hacettepe University Faculty of Medicine M Alikaşifoğlu
More informationMetabolic Dr Elizabeth Mumper
MINDD Forum General Session Metabolic Elizabeth Mumper, MD Director of Medical Education Autism Research Institute May 2009 Vicious Cycles Food sensitivities Gut inflammation Malabsorption oxidative stress
More informationMeeting folate and related B-vitamin requirements through food: Is it enough? Role of fortification and dietary supplements
Meeting folate and related B-vitamin requirements through food: Is it enough? Role of fortification and dietary supplements Helene McNulty PhD RD Northern Ireland Centre for Food and Health (NICHE) University
More informationLaboratory Bulletin...
Laboratory Bulletin... Updates and Information from Rex Healthcare and Rex Outreach September 1997 Issue Number 24 Homocysteine and vascular risk Introduction: This past June, the New England Journal of
More informationTopic 1: Lifestyle, Health and Risk
alevelbiology.co.uk Topic 1: Lifestyle, Health and Risk SPECIFICATION Many animals have a heart and circulation (mass transport to overcome limitations of diffusion in meeting the requirements of organisms).
More informationHyperhomocysteinaemia in Black patients with cerebral thrombosis
Q J Med 1997; 90:635-639 Hyperhomocysteinaemia in Black patients with cerebral thrombosis R. DELPORT 1, J.B. UBBINK\ W.J.H. VERMAAK 1, H. ROSSOUW 1, P.J. BECKER 2 andj. JOUBERT 3 * From the ^Department
More informationImpact of Serum Homocysteine on Platelet Count in Stable Hemodialysis Patients
Impact of Serum Homocysteine on Platelet Count in Stable Hemodialysis Patients Hamid Nasri, MD Hemodialysis Section, Hajar Medical, Educational and Therapeutic Center, Shahrekord University of Medical
More informationHyperhomocysteinemia is associated with increased risk
Supplementation of Atherogenic Diet With B Vitamins Does Not Prevent Atherosclerosis or Vascular Dysfunction in Monkeys Steven R. Lentz, MD, PhD; Donald J. Piegors, MBA; M. René Malinow, MD; Donald D.
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationAmino acid metabolism I
Amino acid metabolism I Jana Novotná Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ. Metabolic relationship of amino acids DIETARY PROTEINS GLYCOLYSIS
More informationPlasma Homocysteine Concentrations in a Healthy Population Living in Burkina Faso
CURRENT THERAPEUTIC RESEARCH@ VOL 61, No 9, SEPTEMBER 2000 Plasma Homocysteine Concentrations in a Healthy Population Living in Burkina Faso Jacques Simpork, Salvatore Pignatelli, Sergio Barlati,* Mariano
More informationHomocysteine ELISA. Product information Information about other products is available at: Userś Manual
Product information Information about other products is available at: www.demeditec.com Userś Manual Homocysteine ELISA Enzyme immunoassay for the quantitative determination of total L-homocysteine in
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationCONTRAINDICATIONS None (4)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cystadane safely and effectively. See full prescribing information for Cystadane. Cystadane (betaine
More informationHomocysteine levels and cardiovascular disease in migraine with aura
J Headache Pain (2003) 4:62 66 DOI 10.1007/s10194-003-0032-y ORIGINAL Eleonora Ferraris Nadia Marzocchi Daria Brovia Carmela N. Castellana Luigi A. Pini Homocysteine levels and cardiovascular disease in
More informationProtein-bound Homocyst(e)ine A Possible Risk Factor for Coronary Artery Disease
Protein-bound Homocyst(e)ine A Possible Risk Factor for Coronary Artery Disease Soo-Sang Kang, Paul W. K. Wong, Heron Y. Cook, Marija Norusis, and Joseph V. Messer Departments ofpediatrics, Preventive
More informationBachelor Nutrition Science Seminar Nutritional Biochemistry (Module BE2.3) Topics
Nutritional Biochemistry (Module BE2.3) Prof. Dr. Stefan Lorkowski 1 Bachelor Nutrition Science Seminar Nutritional Biochemistry (Module BE2.3) Topics Biosynthesis of amino acids 1. Amino acids: general
More informationIOM DRI Research Synthesis Workshop June 7-8, 2006
Discussion of Research Recommendations: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Dietary Reference Intake Research Synthesis Workshop DRI Report on B
More informationLipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry
Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationLaboratory Evaluation of Venous Thrombosis Risk
Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic
More informationSecrets of delaying aging and living disease free Part 1
Secrets of delaying aging and living disease free Part 1 Roman Pawlak, Ph.D, RD www.drromanpawlak.com Aging results in profound changes that effect all systems, organs and tissues. Pawlak R. Forever young.
More informationCLINICAL CHEMISTRY Review Article. 1985, Boers 12 described accelerated vascular disease associmature
CLINICAL CHEMISTRY Review Article H y p e r h o m o c y s t e i n e m i a An Emerging and Important Risk Factor for Thromboembolic and Cardiovascular Disease SUSAN C. GUBA, MD, 1 " 3 LOUIS M. FINK, MD,"
More informationCORRELATION OF HOMOCYSTEINE CONCENTRATION WITH PLASMA FIBRINOGEN AND PHYSICAL ACTIVITY IN MALES WITH CORONARY ARTERY DISEASE
CORRELATION OF HOMOCYSTEINE CONCENTRATION WITH PLASMA FIBRINOGEN AND PHYSICAL ACTIVITY IN MALES WITH CORONARY ARTERY DISEASE by Monica R. Prerost Thesis submitted to the faculty of Virginia Polytechnic
More informationState of the art ingredients fast friendly service
ALPHA-LIPOIC ACID An Efficient Antioxidant α-lipoic acid also known as thioctic acid, plays an important role in metabolic processes. It functions as a co-factor for a number of key enzymes that help in
More informationGlossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationRanking Nutritional Supplements Botanical Medicine
Your Monthly Update Dear Colleague Welcome to the October 07 newsletter from Pure Bio Ltd. Did you know...? The high levels of the antioxidants in raspberries can help to combat the harmful effects of
More information